A Deep Learning Approach to Antibiotic Discovery

2020/02/01 by Jonathan M. Stokes, Jonathan Stokes, Kevin Yang +21 · 49 citations
Biochemistry, Genetics and Molecular Biology · Computer Science · #Bacterial Identification and Susceptibility Testing #Biomedical Text Mining and Ontologies #Computational Drug Discovery Methods

paper · pdf · doi:10.1016/j.cell.2020.01.021

crossref issued 2020/02/01 · crossref published 2020/02/01 · crossref published-print 2020/02/01 · openalex publication_date 2020/02/01 · crossref created 2020/02/20 · crossref deposited 2025/09/25 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Cited by

• Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes
• Vowel- and Diphthong-Like Spectral Patterns in Sperm Whale Codas
• Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes**
• The past, present, and future of antibiotics
• Deep learning in image-based phenotypic drug discovery
• Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish
• GraphNorm: A Principled Approach to Accelerating Graph Neural Network Training
• Understanding current challenges of antibiotic resistance to find new solutions for 2050: scientific, medical and political issues
• Rapid accumulation of fluorophores and fast kill identify drugs with bactericidal effects against Gram-negative bacteria
• Deep-learning-enabled antibiotic discovery through molecular de-extinction
• CADD, AI and ML in drug discovery: A comprehensive review
• Cross-disciplinary perspectives on the potential for artificial intelligence across chemistry
• Quantum-computing-enhanced algorithm unveils potential KRAS inhibitors
• AI on Drugs: Can Artificial Intelligence Accelerate Drug Development? Evidence from a Large-Scale Examination of Bio-Pharma Firms
• Antibacterial Drug Discovery: Deep Learning Successes and Challenges through the Structural Biology Lens
• SAAP-148 and halicin exhibit synergistic antimicrobial activity against antimicrobial-resistant bacteria in skin but not airway epithelial culture models
• Microbial Technologies Enhanced by Artificial Intelligence for Healthcare Applications
• Pharmacophore-guided computational modeling of quinolone-ATPase conjugate inhibitors targeting DNA GyrB subunit of Staphylococcus aureus
• Artificial intelligence in drug development
• The future of machine learning for small-molecule drug discovery will be driven by data
• How Artificial Intelligence is Shaping Life Sciences: Systematic Qualitative Review with a Future-oriented Analytical Framework
• Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research
• Discovery of antimicrobial peptides in the global microbiome with machine learning
• How ready are we to use artificial intelligence in our fight against antimicrobial resistance? An ESGAID and EAAS perspective
• An artificial intelligence accelerated virtual screening platform for drug discovery
• Anubis: Bayesian optimization with unknown feasibility constraints for scientific experimentation
• A human metabolic map of pharmacological perturbations reveals drug modes of action
• Relating Graph Neural Networks to Structural Causal Models
• Descriptor and Graph-based Molecular Representations in Prediction of Copolymer Properties Using Machine Learning
• Optimal message passing for molecular prediction is simple, attentive and spatial
• Functional Groups are All you Need for Chemically Interpretable Molecular Property Prediction
• A guide to machine learning for biologists
• Clinically confirmed cohort reveals antioxidant genetic polymorphisms as potential susceptibility factors for long COVID after mild or asymptomatic COVID-19
• Artificial Intelligence in Drug Discovery: Applications and Techniques
• Optimizing Functionals on the Space of Probabilities with Input Convex\n Neural Networks
• Principled Hyperedge Prediction with Structural Spectral Features and Neural Networks
• Multi-view Graph Condensation via Tensor Decomposition
• Boost then Convolve: Gradient Boosting Meets Graph Neural Networks
• Noether Networks: Meta-Learning Useful Conserved Quantities
• Bayesian Graph Neural Networks for Molecular Property Prediction
• Weisfeiler and Leman go sparse: Towards scalable higher-order graph embeddings
• RetroGNN: Approximating Retrosynthesis by Graph Neural Networks for De Novo Drug Design
• Machine Learning Applications for Therapeutic Tasks with Genomics Data
• Symmetry-driven graph neural networks
• Persistent Message Passing
• Reconstruction for Powerful Graph Representations
• Revolutionizing gastroenterology and hepatology with artificial intelligence: From precision diagnosis to equitable healthcare through interdisciplinary practice
• Unraveling the Potential of Diffusion Models in Small Molecule Generation
• The antibiotic resistance crisis and the development of new antibiotics
• Current Approaches and Strategies Applied in First‐in‐class Drug Discovery